Posts tagged “Duke”
Don't be surprised if you are a Triangle resident - even in Durham, a non-AT&T market in the old telco days - and you see an AT&T crew touting "Gigapower" logos on shirts or trucks in the near future. The telecommunications giant is wasting no time in rolling out a fiber-optic network as part of the North Carolina Next Generation Network. With all six cities involved now on board, AT&T is moving fast - the old Ma Bell knows that Google could be a threat. So, too, is RST Fiber which has already targeted Wake Forest for testing. Watch out, folks, fiber is coming quickly.
When the Town of Carrboro inked its agreement with AT&T for deployment of a fiber network, the North Carolina Next Generation Network's goal of bringing ultrafast Internet service took a huge step toward network workout. The next big date: Oct. 1 as NCNGN and partners identify where they want AT&T to provide free net access. But Google Fiber remains an option. WRAL TechWire Insiders get the details.
New technologies including wearable monitors will offer up an abundance of new information - big data - that will transform how patients view and even participate in their own care health care, a Duke study says.
A pouch the size of a fast-food tomato ketchup packet may soon be saving the lives of children born to HIV infected mothers in sub-Saharan Africa, thanks to an award-winning project by students at Duke University's Pratt School of Engineering.
The City of Durham has reached an agreement with AT&T to deploy an ultrafast Internet network as part of the North Carolina Next Generation Network initiative. AT&T is seeking to build a fiber network ahead of Google, which has listed the Triangle as one of the targets for its Google Fiber network. Raleigh has given preliminary approval.
The City of Winston-Salem is the latest municipal participant in the North Carolina Next Generation Network project to make a deal with A&T for the deployment of an ultrafast Internet and entertainment network. Carrboro could be next.
The North Carolina Biotechnology Center awarded $2.5 million in grants and other funding in its most recent quarter. Meanwhile, companies supported by the Center raised some $192 million in outside funding.
W. Mark Crowell, who helped lead tech transfer efforts at Duke, UNC-Chapel Hill and N.S. State as well as the building of NCSU's Centennial Campus, is returning to Chapel Hill after a four-year tenure as the award winning executive director at U. Va. Innovation. The University of Virginia's H. Brevy Cannon interviewed Crowell about the development of the university as a tech transfer and entrepreneurial leader.
W. Mark Crowell, a veteran executive who led technology transfer efforts at UNC-CH, NCSU and Duke, is returning to the Triangle. Crowell is stepping down as executive director of the innovation program at the University of Virginia and plans to become a consultant based in Chapel Hill.
The race to be first to bring gigabit-speed Internet access across the Triangle and Triad may be won by AT&T, not Time Warner Cable or Google Fiber. The North Carolina Next Generation Network consortium says it is recommending that six city governments approve AT&T's proposal. However, the group is not precluding other companies from the project.
Early Thursday, the North Carolina Next Generation Network consortium issued a full statement explaining why it is recommending that six cities in the Triangle and the Triad "enthusiastically approved" support for AT&T's proposal to create an ultra-fast Internet network for the region.
The people spearheading the NCNGN project are pushing ahead with their own plans even as they welcome the news that a Google Fiber network could be headed to the Triangle. "This is great news for the region, but this is still preliminary and our efforts are still continuing," said Elise Kohn
Dr. Victor Dzau, who serves as president and chief executive of Duke University Health System, has been named as the next president of the Institute of Medicine, which plays a lead role in advising Congress on health matters.
Nearly two years after pulling back on IPO plans, Argos Therapeutics is again seeking to go public to finance phase III clinical trials for its kidney cancer immunotherapy. Read more about Argos' plans.
Oxygen Biotherapeutics is prepping to start late-stage clinical trials on a drug candidate that could treat low cardiac outpput syndrome and the company is tapping the cardiac surgery trials experience of the Duke Clinical Research Institute to do it.